International Conference on Advances in Vaccine Research and Development

ICAVRD

3rd Dec – 4th Dec 2026 Melbourne, Australia

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

Credit Card

Debit Card

Net Banking

Cash Card

Unified Payments

Select Registration Mode

Standard / Physical Participation USD

Join us on-site for keynotes, talks, workshops, networking, conference kit and certificate.

Virtual Participation USD

Participate online via live streaming. Includes live access to all sessions, digital materials and certificate.

Participant Details

Full Name *

Email Address *

Mobile Number with Country Code *

City *

State *

Country *

Zip / Postal Code *

Address *

Coupon Code

Terms & Condition

I agree to the Terms & Conditions and Refund & Cancellation Policy.

Read the full Terms & Conditions

Registration Summary

Conference ICAVRD

Date 3rd Dec – 4th Dec 2026

Location Melbourne, Australia

Participation Type Listener

Organizer Science Leagues

Registration Mode Standard / Physical

Registration Fee USD 0.00

Bank Convenience Charges (5.8%)i USD 0.00

Calculated based on 5.8% of the registration fee

Discount USD 0.00

Total Payable USD 0.00

100% Secure Payment

Your payment information is encrypted and processed securely.

Conference Session Tracks

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

01 Innovative Vaccine Platforms +

This track will explore cutting-edge vaccine platforms, including mRNA, viral vectors, and nanoparticle-based systems. Discussions will focus on the advantages and challenges of these novel technologies in vaccine development.

SDG 3 SDG 4

02 Immunogen Design and Optimization +

This session will delve into the principles of immunogen design, emphasizing the role of structural biology and computational methods. Participants will discuss strategies for optimizing immunogenicity and specificity in vaccine candidates.

SDG 3 SDG 9

03 Preclinical Studies in Vaccine Research +

This track will highlight the importance of preclinical studies in evaluating vaccine candidates. Presentations will cover various animal models, endpoints, and methodologies used to assess safety and efficacy.

SDG 3 SDG 9

04 Vaccine Efficacy and Safety Assessment +

This session will focus on the methodologies for assessing vaccine efficacy and safety in clinical trials. Experts will discuss statistical approaches and regulatory considerations in vaccine evaluation.

SDG 3 SDG 9

05 Advancements in Vaccine Formulation +

This track will address the latest advancements in vaccine formulation technologies, including adjuvants and delivery systems. The goal is to enhance stability, immunogenicity, and patient compliance.

SDG 3 SDG 9

06 Translational Research in Vaccinology +

This session will explore the translation of basic vaccine research into clinical applications. Discussions will focus on bridging the gap between laboratory findings and real-world vaccine deployment.

SDG 3 SDG 9

07 Vaccine Production Technologies +

This track will examine the latest technologies in vaccine production, including cell culture, fermentation, and purification processes. Participants will discuss scalability and cost-effectiveness in vaccine manufacturing.

SDG 9 SDG 17

08 Regulatory Challenges in Vaccine Development +

This session will address the regulatory landscape surrounding vaccine development and approval. Experts will discuss the challenges and strategies for navigating regulatory pathways in different regions.

SDG 3 SDG 16

09 Global Vaccination Strategies and Policies +

This track will focus on global vaccination strategies and public health policies aimed at increasing vaccine coverage. Discussions will include the role of international organizations and government initiatives.

SDG 3 SDG 17

10 Emerging Infectious Diseases and Vaccine Response +

This session will explore the role of vaccines in combating emerging infectious diseases. Participants will discuss rapid response strategies and the importance of vaccine preparedness in global health.

SDG 3 SDG 3

11 Ethical Considerations in Vaccine Research +

This track will address the ethical implications of vaccine research and development. Topics will include informed consent, equitable access, and the ethical use of human and animal subjects in research.

SDG 3 SDG 10